[go: up one dir, main page]

YU62991A - Karbapenemska jedinjenja - Google Patents

Karbapenemska jedinjenja

Info

Publication number
YU62991A
YU62991A YU62991A YU62991A YU62991A YU 62991 A YU62991 A YU 62991A YU 62991 A YU62991 A YU 62991A YU 62991 A YU62991 A YU 62991A YU 62991 A YU62991 A YU 62991A
Authority
YU
Yugoslavia
Prior art keywords
group
piperazinyl
pyrrolidinyl
substituted
group derived
Prior art date
Application number
YU62991A
Other languages
English (en)
Inventor
S.L. Dax
D.D. Keith
P.L. Rossman
Original Assignee
F. Hoffmann-La Roche Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag. filed Critical F. Hoffmann-La Roche Ag.
Publication of YU62991A publication Critical patent/YU62991A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/26—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 4
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

KARBAPENEMSKA JEDINJENJA, opšte formule I u kojoj R označava vodonik ili grupu koja štiti karboksilnu kiselinu; R1 je odabran iz grupe koja se sastoji od vodonika, niže alkil-, niže alkoksi- i hidroksi-alkil-grupe; R2 i R3 su svaki nezavisno jedan od drugog vodonik, niži alkil, niži alkoksi ili niži alkiltio; i Y je (i)estarska grupa (ii)tioestarska grupa; (iii)karbamatna grupa koja se izvodi od piperazinila ili pirolidinila; (iv)aminska grupa koja se izvodi od piperazinila; (v)kvaternerna amonijum-grupa koja se izvodi od piperazinila; ili (vi)grupa koja obuhvata kovalentnu vezu; pri čemu su estarska grupa i tioestarska grupa vezane za supstituisanu hinolonil- ili naftiridonil-grupu; karbamatna grupa koja se izvodi iz piperazinila ili pirolidinila, aminska grupa koja se izvodi iz piperazinila i kvaternerna amonijum-grupa koja se izvodi iz piperazinila sadrže piperazinil-jezgro ili pirolidinil-jezgro koje ima atom azota direktno vezan za supstituisanu hinolonil- ili naftiridonil grupu, pri čemu su ova piperazinil- i pirolidinil-jezgra nesupstituisana ili supstituisana jednom ili više nižih alkil-grupa; i pri čemu je kovalentna veza odgovarajuće grupe vezana za supstituisanu izotiazolo- ili izoksazolohinolonil- ili naftiridonil-grupu preko atoma azota u izotiazolo- ili izoksazolo-jezgru; kao i odgovarajući lako hidrolizujući estri, farmaceutski prihvatljive soli i hidrati bilo kojeg od prethodnih jedinjenja. Ovi produkti imaju antibakterijsko de jstvo.
YU62991A 1990-04-09 1991-04-08 Karbapenemska jedinjenja YU62991A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50613590A 1990-04-09 1990-04-09

Publications (1)

Publication Number Publication Date
YU62991A true YU62991A (sh) 1994-04-05

Family

ID=24013339

Family Applications (1)

Application Number Title Priority Date Filing Date
YU62991A YU62991A (sh) 1990-04-09 1991-04-08 Karbapenemska jedinjenja

Country Status (17)

Country Link
EP (1) EP0451764A1 (sh)
JP (1) JPH04234884A (sh)
AU (1) AU7420591A (sh)
BR (1) BR9101418A (sh)
CA (1) CA2039987A1 (sh)
CS (1) CS94391A2 (sh)
FI (1) FI911666A (sh)
HU (1) HUT57769A (sh)
IE (1) IE911161A1 (sh)
IL (1) IL97797A0 (sh)
MC (1) MC2262A1 (sh)
MX (1) MX25231A (sh)
NO (1) NO911357L (sh)
PT (1) PT97287A (sh)
TW (1) TW216420B (sh)
YU (1) YU62991A (sh)
ZA (1) ZA912279B (sh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0997466A1 (en) * 1988-10-24 2000-05-03 PROCTER & GAMBLE PHARMACEUTICALS, INC. Novel antimicrobial lactam-quinolones
US5180719A (en) * 1988-10-24 1993-01-19 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactam esters
US5491139A (en) * 1988-10-24 1996-02-13 The Procter & Gamble Company Antimicrobial quinolonyl lactams
CA2001203C (en) * 1988-10-24 2001-02-13 Thomas P. Demuth, Jr. Novel antimicrobial dithiocarbamoyl quinolones
US5273973A (en) * 1988-10-24 1993-12-28 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl esters
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
ES2147721T3 (es) * 1990-04-18 2000-10-01 Procter & Gamble Pharma Quinolonil lactamas antimicrobianas.
HUT67423A (en) * 1991-10-01 1995-04-28 Procter & Gamble Pharma Process for the production of antimicrobal compounds containing quinolone moiety and beta-lactam moiety
DE4234078A1 (de) * 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren
DE4234330A1 (de) * 1992-10-12 1994-04-14 Bayer Ag Chinoloncarbonsäuren
KR100242355B1 (ko) * 1994-08-02 2000-03-02 데이비드 엠 모이어 항미생물 화합물의 제조 방법
AU3154095A (en) * 1994-08-02 1996-03-04 Procter & Gamble Company, The Process for making quinolonyl lactam antimicrobials and novel intermediate compounds
US5607928A (en) * 1994-08-05 1997-03-04 Zeneca Limited Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives
EP0695753A1 (en) * 1994-08-05 1996-02-07 Zeneca Limited Carbapenem derivatives containing a bicyclic substituent, process for their preparation, and their use
US5973142A (en) * 1997-01-21 1999-10-26 Yasuda; Nobuyoshi Process for synthesizing carbapenem intermediates
JP2001519773A (ja) * 1997-01-21 2001-10-23 メルク エンド カンパニー インコーポレーテッド カルバペネム中間体の合成プロセス
US6080854A (en) * 1997-08-25 2000-06-27 Merck & Co., Inc. Process for synthesizing carbapenem intermediates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1179675A (en) * 1981-01-30 1984-12-18 Erwin Gotschi 7-oxo-1-azabicyclo ¬3,2,0| heptene-2-derivatives
US4680292A (en) * 1984-12-13 1987-07-14 Merck & Co., Inc. Carbapenems and 1-methylcarbapenems having a 2-heteroaryliumaliphatic substituent
US4767762A (en) * 1985-12-23 1988-08-30 Abbott Laboratories Tricyclic quinoline and naphthyride antibacterials
EP0997466A1 (en) * 1988-10-24 2000-05-03 PROCTER & GAMBLE PHARMACEUTICALS, INC. Novel antimicrobial lactam-quinolones
EP0366193A3 (en) * 1988-10-24 1992-01-08 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial quinolonyl lactams
ES2148135T3 (es) * 1988-10-24 2000-10-16 Norwich Eaton Pharma Nuevos esteres antimicrobianos de quinolonil lactamas.

Also Published As

Publication number Publication date
HUT57769A (en) 1991-12-30
ZA912279B (en) 1992-02-26
JPH04234884A (ja) 1992-08-24
NO911357L (no) 1991-10-10
EP0451764A1 (en) 1991-10-16
MX25231A (es) 1993-10-01
HU911132D0 (en) 1991-10-28
CA2039987A1 (en) 1991-10-10
TW216420B (sh) 1993-11-21
FI911666A (fi) 1991-10-10
AU7420591A (en) 1991-10-10
NO911357D0 (no) 1991-04-08
BR9101418A (pt) 1991-11-26
PT97287A (pt) 1992-01-31
IE911161A1 (en) 1991-10-09
MC2262A1 (fr) 1993-04-26
CS94391A2 (en) 1991-11-12
IL97797A0 (en) 1992-06-21
FI911666A0 (fi) 1991-04-08

Similar Documents

Publication Publication Date Title
YU62991A (sh) Karbapenemska jedinjenja
EE200100589A (et) Kinoliini derivaadid MEK ensüümide inhibiitoritena
TW349098B (en) Naphthalene derivatives, process for the preparation thereof, and intermediates therefor
DK0638585T3 (da) 5-O-desosaminylerythronolid-A-derivater
RS49906B (sr) Benzociklohepteni, postupak za njihovo dobijanje, farmaceutski preparati koji ove sadrže kao i njihova primena za izradu lekova
MA22581A1 (fr) Derives de l'hydrazine a activite pharmacologique et leur procede de preparation
YU19494A (sh) Derivati cefalosporina
ES2115600T3 (es) Derivados de 1-metilcarbapenem y procedimiento para su preparacion.
IE802360L (en) Azetidine derivatives
YU46547B (sh) 1,4-dihidropiridini i postupak za njihovo dobijanje
DE69232681D1 (de) 4-oxozyklische harnstoffe mit antiarrhythmische und entfibrillatorische wirkung
YU45695B (sh) Postupak za dobijanje novih 6-alkiliden-penema sa beta-laktamaza inhibitorskim i antibakterijskim osobinama
GB1427139A (en) Penicillins
YU21391A (sh) Triciklični-ciklični amini kao novi inhibitori holinesteraze
YU65899A (sh) Stabilizovani karbapenem intermedijari i sintetska upotreba
ATE272635T1 (de) Neue naphthyridinderivate.
YU46703B (sh) Postupak za dobijanje hinolinskih derivata
ATE3769T1 (de) 1-imidazol-2-yliden-3-thienyl-harnstoffderivate verfahren zu deren herstellung und pharmazeutische zusammensetzungen.
DE69232825D1 (de) Zyklische Harnstoffe mit antiarrhythmischer und antifibrillatorischer Wirkung
AU539986B2 (en) Nitroso-urea compounds + alkylene amine derivatives of ureas
ES2095969T3 (es) Derivados de quinona.
ES2085738T3 (es) Derivados de tetrahidronaftaleno su preparacion y su aplicacion en terapeutica.
YU80593A (sh) Cefalosporinske soli i postupci za njihovu proizvodnju
SE7910387L (sv) 7alfa-metoxicefalosporinderivat och forfarande for framstellning derav
JPS55160779A (en) Azeto 1,2-a thieno 2,3-c pyridine derivative